Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|9|1343-1353

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.9, 2011-09, pp. : 1343-1353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial dysfunction in atherosclerosis

By Callow A.D.  

General Pharmacology, Vol. 38, Iss. 5, 2002-05 ,pp. : 257-258

Elsevier

Access to resources Recommend Favorite

Oxidative Stress, Endothelial Dysfunction and Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 15, Iss. 26, 2009-09 ,pp. : 2988-3002

Bentham Science Publishers

Access to resources Recommend Favorite

The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 35, 2008-12 ,pp. : 3700-3714

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Dysfunction, Hypertension and Atherosclerosis: A Review of the Effects of Lacidipine

By Haller H.   Cosentino F.   Lüscher T.F.  

Drugs in R&D, Vol. 3, Iss. 5, 2002-01 ,pp. : 311-323

Adis International

Access to resources Recommend Favorite

Vasoactive substances - Nitric oxide and endothelial dysfunction in atherosclerosis

By Russo G.   Leopold J.A.   Loscalzo J.  

General Pharmacology, Vol. 38, Iss. 5, 2002-05 ,pp. : 259-269

Elsevier

Access to resources Recommend Favorite